Financial Performance Forecast - The company expects a net loss of between 230 million to 280 million yuan for the first half of 2024, compared to a loss of 932.59 million yuan in the same period last year[3]. - The net profit attributable to shareholders is projected to increase by 75.34% to 69.98%, compared to a loss of 932.59 million yuan in the previous year[3]. - The basic earnings per share are expected to be a loss of between 0.0893 yuan to 0.1087 yuan per share, improving from a loss of 0.3621 yuan per share last year[3]. - The performance forecast period is from January 1, 2024, to June 30, 2024, and the forecast has not been audited by an accounting firm[7]. Cost Management and Operational Efficiency - The company has benefited from a 5% VAT reduction for advanced manufacturing, leading to increased other income[13]. - The company has seen a decrease in inventory and product costs, resulting in reduced inventory impairment provisions[16]. - The chlor-alkali segment has turned profitable due to lower procurement prices for key raw materials like coal and coke, alongside ongoing cost reduction efforts[15]. - The losses from joint ventures have decreased compared to the same period last year[8]. Investor Caution - The company emphasizes that the performance forecast is based on preliminary calculations and the final financial data will be disclosed in the 2024 semi-annual report[5]. - The company warns investors to make cautious decisions and be aware of investment risks[5].
中泰化学(002092) - 2024 Q2 - 季度业绩预告